A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies - Concepedia

Concepedia

Publication | Open Access

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

DOI Full Paper Access

78

Citations

41

References

2019

Year

Darren C. Phillips, Sha Jin, Gareth P. Gregory, Qi Zhang, John Xue, Xiaoxian Zhao, Jun Chen, Yunsong Tong, Haichao Zhang, Morey L. Smith,

References

	Year	Citations

Page 1